Nektar's $325M offering; Maze stock rises; Merck deal rumors; BMS layoffs

Nektar Therapeutics prices $325 million public offering: The Bay Area biotech is selling about 3.5 million shares of stock at $92 per share. The proceeds will fund “general corporate purposes,” including ...